Related Experiment Video

Updated: Aug 17, 2026

The Soft Agar Colony Formation Assay
08:01

The Soft Agar Colony Formation Assay

Published on: October 27, 2014

Ionomycin downregulates beta-catenin/Tcf signaling in colon cancer cell line

Chi Hoon Park1, Eun Ryeong Hahm, Ju Hyung Lee

  • 1Division of Chemistry and Molecular Engineering, Seoul National University, Seoul 151-742, Korea.

Carcinogenesis
|June 3, 2005
PubMed

Insights

Ionomycin effectively inhibits beta-catenin/Tcf signaling, a key pathway in colorectal cancer development. This compound reduces nuclear beta-catenin and Tcf complex DNA binding, offering a potential therapeutic strategy for colon cancer.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Signaling

Background:

  • Beta-catenin/Tcf signaling is crucial for initiating colorectal cancer.
  • Understanding regulators of this pathway is vital for cancer therapy.

Purpose of the Study:

  • To investigate the effect of ionomycin on beta-catenin/Tcf signaling in colon cancer cells.
  • To elucidate the inhibitory mechanism of ionomycin.

Main Methods:

  • Reporter gene assays to measure signaling activity.
  • Immunoprecipitation and Western blot to analyze protein interactions and levels.
  • Electrophoretic mobility shift assays (EMSA) to assess DNA-binding activity.

Main Results:

  • Ionomycin significantly inhibited beta-catenin/Tcf signaling.
  • The drug disrupted the association between beta-catenin and Tcf-4.
  • Ionomycin decreased nuclear beta-catenin levels and suppressed Tcf complex binding to DNA.

Conclusions:

  • Ionomycin acts as a negative regulator of beta-catenin/Tcf signaling in colon cancer.
  • Its mechanism involves reducing nuclear beta-catenin and impairing Tcf DNA binding.
  • Ionomycin presents a potential therapeutic agent for colorectal cancer.

More Related Videos

In vitro Organoid Culture of Primary Mouse Colon Tumors07:33

In vitro Organoid Culture of Primary Mouse Colon Tumors

Published on: May 17, 2013

Related Concept Videos

Catenins01:23

Catenins

Catenins are characterized by multiple binding domains and dynamic structures that allow them to function as linker proteins in cell junction complexes. All catenins, except α-catenin, contain a characteristic protein sequence called the armadillo repeat and are therefore also called armadillo proteins.
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...